134 related articles for article (PubMed ID: 37160667)
41. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
Moreau A; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
[TBL] [Abstract][Full Text] [Related]
42. [Effect of nonsteroidal antiinflammatory drugs on colonic lipoxygenase and cyclooxygenase activities from patients with colonic neoplasia].
Di Girolamo G; Franchi A; De Los Santos AR; Martí ML; Farina M; Fernández de Gimeno MA
Medicina (B Aires); 2001; 61(5 Pt 1):566-72. PubMed ID: 11721323
[TBL] [Abstract][Full Text] [Related]
43. Synthesis of stable platinum complexes containing carborane in a carrier group for potential BNCT agents.
Yoo J; Do Y
Dalton Trans; 2009 Jul; (25):4978-86. PubMed ID: 19662290
[TBL] [Abstract][Full Text] [Related]
44. Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.
Celotti F; Laufer S
Pharmacol Res; 2001 May; 43(5):429-36. PubMed ID: 11394934
[TBL] [Abstract][Full Text] [Related]
45. COX-1/COX-2 inhibitors based on the methanone moiety.
Dannhardt G; Fiebich BL; Schweppenhäuser J
Eur J Med Chem; 2002 Feb; 37(2):147-61. PubMed ID: 11858847
[TBL] [Abstract][Full Text] [Related]
46. Molecular Dynamics Simulation of Cyclooxygenase-2 Complexes with Indomethacin closo-Carborane Analogs.
Sárosi MB; Lybrand TP
J Chem Inf Model; 2018 Sep; 58(9):1990-1999. PubMed ID: 30067351
[TBL] [Abstract][Full Text] [Related]
47. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential.
Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM
Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202
[TBL] [Abstract][Full Text] [Related]
48. Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer: synthesis and biological studies.
Bhardwaj A; Kaur J; Wuest F; Knaus EE
ChemMedChem; 2014 Jan; 9(1):109-16, 240. PubMed ID: 24376205
[TBL] [Abstract][Full Text] [Related]
49. In vitro COX-1 and COX-2 enzyme inhibitory activities of iridoids from Penstemon barbatus, Castilleja tenuiflora, Cresentia alata and Vitex mollis.
Ramírez-Cisneros MÁ; Rios MY; Aguilar-Guadarrama AB; Rao PP; Aburto-Amar R; Rodríguez-López V
Bioorg Med Chem Lett; 2015 Oct; 25(20):4505-8. PubMed ID: 26351040
[TBL] [Abstract][Full Text] [Related]
50. Molecular Modeling of the Interactions between Carborane-Containing Analogs of Indomethacin and Cyclooxygenase-2.
Sárosi MB; Neumann W; Lybrand TP; Hey-Hawkins E
J Chem Inf Model; 2017 Aug; 57(8):2056-2067. PubMed ID: 28632381
[TBL] [Abstract][Full Text] [Related]
51. Acridine/Acridone-Carborane Conjugates as Strong DNA-Binding Agents with Anticancer Potential.
Różycka D; Kowalczyk A; Denel-Bobrowska M; Kuźmycz O; Gapińska M; Stączek P; Olejniczak AB
ChemMedChem; 2023 Apr; 18(7):e202200666. PubMed ID: 36734215
[TBL] [Abstract][Full Text] [Related]
52. CarbORev-5901: The First Carborane-Based Inhibitor of the 5-Lipoxygenase Pathway.
Kuhnert R; Sárosi MB; George S; Lönnecke P; Hofmann B; Steinhilber D; Murganic B; Mijatovic S; Maksimovic-Ivanic D; Hey-Hawkins E
ChemMedChem; 2017 Jul; 12(13):1081-1086. PubMed ID: 28569429
[TBL] [Abstract][Full Text] [Related]
53. Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells.
Ganesh R; Marks DJ; Sales K; Winslet MC; Seifalian AM
World J Surg Oncol; 2012 Sep; 10():200. PubMed ID: 23013454
[TBL] [Abstract][Full Text] [Related]
54. 1-(4-Methane(amino)sulfonylphenyl)-3-(4-substituted-phenyl)-5-(4-trifluoromethylphenyl)-1H-2-pyrazolines/pyrazoles as potential anti-inflammatory agents.
Abdellatif KR; Elshemy HA; Azoz AA
Bioorg Chem; 2015 Dec; 63():13-23. PubMed ID: 26398140
[TBL] [Abstract][Full Text] [Related]
55. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Crew TE; Elder DJ; Paraskeva C
Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
[TBL] [Abstract][Full Text] [Related]
57. Non-steroidal anti-inflammatory agents, Part 19. E-2-pyrrolizin-5-yl acrylic acids as potent dual or selective inhibitors of bovine cyclooxygenase and 5-lipoxygenase.
Dannhardt G; Kiefer W; Nowe U
Arch Pharm (Weinheim); 1995 Sep; 328(9):681-6. PubMed ID: 7487426
[TBL] [Abstract][Full Text] [Related]
58. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors.
Scholz M; Blobaum AL; Marnett LJ; Hey-Hawkins E
Bioorg Med Chem; 2011 May; 19(10):3242-8. PubMed ID: 21524587
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX.
Huang Y; Zhang B; Li J; Liu H; Zhang Y; Yang Z; Liu W
Eur J Med Chem; 2019 Oct; 180():41-50. PubMed ID: 31299586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
